Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT01382277
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT01382277
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01382277. Allocation not applicable; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
- Acronym
- REDUCT
- Condition
- Hyperlipidemia
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- Peking University First Hospital
Record details
- Record id
cardio:ct-nct01382277- Content hash
a910aaea71860129e020031fb8768d4fc0b56b47a9325990506a9a561fcd1338